News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,395 Results
Type
Article (763)
Company Profile (19)
Press Release (12613)
Section
Business (4508)
Career Advice (17)
Deals (658)
Drug Delivery (2)
Drug Development (2361)
Employer Resources (2)
FDA (213)
Job Trends (277)
News (7280)
Policy (388)
Tag
Academia (39)
Adcomms (4)
Allergies (5)
Alliances (1223)
ALS (1)
Alzheimer's disease (12)
Antibody-drug conjugate (ADC) (13)
Approvals (206)
Artificial intelligence (5)
Bankruptcy (4)
Best Places to Work (221)
BIOSECURE Act (5)
Biosimilars (1)
Biotechnology (15)
Bladder cancer (1)
Cancer (70)
Cardiovascular disease (8)
Career advice (10)
CAR-T (10)
Cell therapy (37)
Clinical research (1816)
Collaboration (40)
Compensation (22)
COVID-19 (117)
CRISPR (7)
C-suite (18)
Cystic fibrosis (1)
Data (71)
Diabetes (6)
Diagnostics (33)
Drug discovery (3)
Drug pricing (1)
Earnings (1432)
Editorial (2)
Employer resources (2)
Events (2450)
Executive appointments (42)
FDA (253)
Funding (33)
Gene editing (11)
Gene therapy (24)
GLP-1 (20)
Government (52)
Guidances (4)
Healthcare (386)
Immunology and inflammation (5)
Infectious disease (118)
Inflammatory bowel disease (7)
Intellectual property (4)
Interviews (3)
IPO (362)
Job creations (62)
Job search strategy (10)
Kidney cancer (1)
Labor market (4)
Layoffs (15)
Legal (67)
Liver cancer (1)
Lung cancer (6)
Lymphoma (13)
Machine learning (1)
Management (1)
Manufacturing (16)
MASH (1)
Medical device (64)
Medtech (64)
Mergers & acquisitions (316)
Metabolic disorders (10)
Neurodegenerative disease (6)
Neuroscience (23)
NextGen: Class of 2025 (141)
Non-profit (21)
Now hiring (1)
Obesity (3)
Opinion (1)
Ovarian cancer (1)
Pain (8)
Pancreatic cancer (1)
Parkinson's disease (4)
Patents (11)
Patient recruitment (5)
People (1723)
Pharmacy benefit managers (1)
Phase I (827)
Phase II (881)
Phase III (528)
Pipeline (49)
Policy (11)
Postmarket research (25)
Preclinical (279)
Press Release (1)
Prostate cancer (3)
Radiopharmaceuticals (2)
Rare diseases (12)
Real estate (113)
Recruiting (1)
Regulatory (336)
Reports (3)
Research institute (63)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (9)
Series B (3)
Service/supplier (1)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (2)
Startups (108)
Supply chain (2)
Tariffs (2)
Vaccines (17)
Venture capital (1)
Weight loss (1)
Date
Today (4)
Last 7 days (18)
Last 30 days (51)
Last 365 days (871)
2025 (492)
2024 (1031)
2023 (1276)
2022 (1611)
2021 (1651)
2020 (1260)
2019 (736)
2018 (544)
2017 (663)
2016 (547)
2015 (598)
2014 (400)
2013 (341)
2012 (296)
2011 (299)
2010 (316)
Location
Africa (14)
Arizona (1)
Asia (1097)
Australia (96)
California (349)
Canada (94)
China (22)
Colorado (2)
Connecticut (8)
Delaware (6)
Europe (1282)
Florida (19)
Idaho (1)
Illinois (7)
India (2)
Indiana (1)
Japan (9)
Maryland (51)
Massachusetts (163)
Michigan (4)
Minnesota (4)
Nevada (1)
New Jersey (53)
New Mexico (1)
New York (31)
North Carolina (14)
North Dakota (1)
Northern California (130)
Oklahoma (1)
Pennsylvania (52)
South America (9)
Southern California (130)
Texas (30)
United States (796)
Utah (2)
Washington D.C. (2)
Washington State (12)
Wisconsin (2)
13,395 Results for "coda biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
In Tough Market, CODA Quietly Shuts Doors
As life sciences companies feel the burn of the current economy, one Bay Area biotech, CODA Biotherapeutics, quietly shut its doors.
March 8, 2023
·
1 min read
·
Kate Goodwin
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
July 16, 2025
·
8 min read
Press Releases
Chair of Sernova Biotherapeutics Resigns
May 26, 2025
·
1 min read
Press Releases
Calidi Biotherapeutics Announces Shareholder Letter from CEO
June 27, 2025
·
6 min read
Business
CODA Biotherapeutics Names Susan Catalano, Ph.D., as Chief Scientific Officer
CODA Biotherapeutics, Inc. today announced the appointment of Susan Catalano, Ph.D., as chief scientific officer.
March 8, 2022
·
3 min read
Press Releases
Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®)
July 15, 2025
·
7 min read
Press Releases
Artiva Biotherapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
May 29, 2025
·
3 min read
Press Releases
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
July 10, 2025
·
5 min read
Press Releases
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24
July 23, 2025
·
4 min read
1 of 1,340
Next
